期刊文献+

异基因造血干细胞移植导致的可逆性后部白质脑病综合征 被引量:4

Reversible posterior leukoencephalopathy syndrome caused by allogeneic hematopoietic stem cell transplantation
下载PDF
导出
摘要 可逆性后部白质脑病综合征是异基因造血干细胞移植后常见并发症之一,病因主要是预处理方案中大剂量放化疗和免疫抑制剂的应用,另外与感染、抗感染治疗和移植后排斥反应有关。发病机制是脑血管自动调节障碍与内皮损伤、交感神经分布差异与高血压脑血管痉挛。临床表现多以抽搐为首发,多有视力下降、血压增高、头痛、意识和精神行为改变。全身症状可有代谢紊乱、低镁血症、低胆固醇血症、肾功能衰竭。可逆性后部白质脑病综合征一个重要特点是其临床和影像学的可逆性,异基因造血干细胞移植后仅少数患者在数周内痊愈,长时间抽搐、伴缺血性改变者预后不良。 Reversible posterior leukoencephalopathy syndrome is one of the common complications after allogeneic hematopoietic stem cell transplantation. The main etiologies of reversible posterior leukoencephalopathy syndrome are high-dose radiotherapy and chemotherapy in preparation, and the application of ~mmunosuppressive agents. Besides those, they may related to infections, anti-infection treatment and graft-versus-host disease. Its pathogenesis includes cerebrovascular autoregulation impaired and endothelial damage, differences in the distribution of sympathetic in cerebral vasospasm, as well as hypertension. Its first symptom is hyperspasmia, and the other clinical manifestations are hypopsia, hypertension, headache, awareness and mental behavioral changes. The general syndromes include metabolism disorder hypomagnesemia, low hypercholesterolemia, and renal function failure. The clinical manifestations and imaging are reversible, which is an important feature of reversible posterior leukoencephalopathy syndrome. A small number of patients were cured for several weeks after transplantation. Patient with tong seizure and ischemic change often have a poor prognosis.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第36期7159-7162,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献26

  • 1Hinchey J,Chaves C,Appignani B, et al. A reversible posterior leukoencephalopat hy syndrome. [J ] N Engl Med ,1996 ,334 (8) :494-500.
  • 2Lee VH, Wijdicks EFM, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65(2):205-210.
  • 3C. Rowley, J. Onslow.Posterior reversible encephalopathy syndrome (PRES).International Journal of Obsteric Anesthesia2008;17(2):195-196.
  • 4Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.Bone Marrow Transplant. 1991;8:393-401.
  • 5Zimmer WE, Hourihane JM, Wang HZ, et al. The effect of human leukocyte antigen disparity on cyclosporin neurotoxicity after allogeneic bone marrow transplantation. AJNR Am J Neuroradiol. 1998;19:601-608.
  • 6Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261–269.
  • 7Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephatopathy syndrome. AJ NR Am J Neuroradiol.2007;28(7): 1320-1327.
  • 8Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation.AJN,R Am J Neuroradiol. 2008;29(5):924-930.
  • 9Burt RK, Wilson WH. Conditioning (preparative) regimens. In: Burt RK, Deeg H J, Lothian ST, Santos GW, eds. Bone Marrow Transplant. Georgetown, Tex:Landes Bioscience.1996;(1): 94-108.
  • 10Covarrubias D J, Leutmer PH, Campeau NG Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol. 2002; 23(6): 1038-1048.

二级参考文献15

共引文献8

同被引文献25

  • 1周志虹,孟玉梅.老年性高血压合并痴呆的相关因素分析及护理决策[J].浙江中医药大学学报,2011,35(2):268-269. 被引量:16
  • 2谢娟.癌痛规范化治疗的护理进展[J].实用临床医药杂志,2013,17(8):136-138. 被引量:18
  • 3Hinchey J,Chuves C, Appignani B,et al. A reversible posterior leukoencephalopathy syndrome[J]. N Engl J Med, 1996,334(8):494-500.
  • 4Birol Baytan, MD, Ozlem Ozdemir,MD,Metin Demirkaya, MD,et al. Reversible posterior leukoencephalopathy induced by cancer chemotherapy [ J] . Pediatr Neurol,2010,43 : 197-201,.
  • 5Fukuyama T,Tanaka M,Nakazawa Y, et al. Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome [ J ] . Pediatr Transplantation, 2011 ,15; E169-E173.
  • 6Tetsuhiro Fukuyama,Miyuki Tanaka,Yozo Nakazawa,et al. Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome[J]. Pediatr Transplantation ’2011, 15: E169-E173.
  • 7Steven K,Feske M D. Posterior reversible encephalopathy Syndrome: A Review[J].Semin Neurol, 2011,31 : 202-215.
  • 8Roth C,Ferbert A. The posterior reversible encephalopathy syndrome: whaty s certain, what,s new [ J] . Pract Neurol, 2011,11: 136-144.
  • 9Deborah Siegal,Anne Keller,Wei Xu, et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation:Incidence, manifestations, and clinical Signifi-cance[J]. Biology of Blood and Marrow Transplantation, 2007 , 13:1 369-1 379.
  • 10尹綺琪,黎永信,李澤荷,等?Reversible posterior leukoencephalopathy syndrome in Chinese children induced by chemotherapy: a. review of five cases[J]. Hong Kong Med J,2011,17:61-66.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部